Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single Tablets
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to establish bioequivalence of two FDC tablets and the
single tablets when administered together after a high fat high caloric meal.